| 1 |
Leuprolide FDA Label
|
| 2 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1175).
|
| 3 |
ClinicalTrials.gov (NCT05701007) Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
|
| 4 |
ClinicalTrials.gov (NCT05087706) Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland CancerMAPS?Unknown status
|
| 5 |
ClinicalTrials.gov (NCT02366494) Micro RNAs to Predict Response to Androgen Deprivation Therapy
|
| 6 |
ClinicalTrials.gov (NCT02269072) Testosterone Regulation of the Natriuretic Peptide System
|
| 7 |
ClinicalTrials.gov (NCT02122198) Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
| 8 |
ClinicalTrials.gov (NCT01546454) Relationship Between the Menstrual Cycle and Heart Disease in Women
|
| 9 |
ClinicalTrials.gov (NCT00514917) A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)
|
| 10 |
ClinicalTrials.gov (NCT00860158) Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer
|
| 11 |
ClinicalTrials.gov (NCT00225420) Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
|
| 12 |
ClinicalTrials.gov (NCT00454571) Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer
|
| 13 |
ClinicalTrials.gov (NCT00687739) Prevention of Obesity in Women Via Estradiol Regulation
|
| 14 |
ClinicalTrials.gov (NCT00193856) RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
|
| 15 |
ClinicalTrials.gov (NCT00452556) The ELDORADO (Eligard, Docetaxel and Radiotherapy) Study
|
| 16 |
ClinicalTrials.gov (NCT01160328) Influence of Male Hormones on Regional Fat Metabolism
|
| 17 |
ClinicalTrials.gov (NCT00817739) Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c
|
| 18 |
ClinicalTrials.gov (NCT00004635) Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
|
| 19 |
ClinicalTrials.gov (NCT00003645) Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
|
| 20 |
ClinicalTrials.gov (NCT01763541) Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading
|
| 21 |
ClinicalTrials.gov (NCT00099086) Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
|
| 22 |
ClinicalTrials.gov (NCT04194554) A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
|
| 23 |
ClinicalTrials.gov (NCT02023463) Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
|
| 24 |
ClinicalTrials.gov (NCT00943956) Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer
|
| 25 |
ClinicalTrials.gov (NCT02064036) Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate
|
| 26 |
ClinicalTrials.gov (NCT03043807) A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
|
| 27 |
ClinicalTrials.gov (NCT03056755) Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
|
| 28 |
ClinicalTrials.gov (NCT02344550) Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer
|
| 29 |
ClinicalTrials.gov (NCT02058706) LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer
|
| 30 |
ClinicalTrials.gov (NCT00161421) Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
|
| 31 |
ClinicalTrials.gov (NCT00903162) Extended Endocrine Therapy for Premenopausal Women With Breast Cancer
|
| 32 |
ClinicalTrials.gov (NCT02772588) AASUR in High Risk Prostate Cancer
|
| 33 |
ClinicalTrials.gov (NCT01750398) Bipolar Androgen-based Therapy for Prostate Cancer (BAT)
|
| 34 |
ClinicalTrials.gov (NCT02716974) A Study of Definitive Therapy to Treat Prostate Cancer
|
| 35 |
ClinicalTrials.gov (NCT02059213) A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer
|
| 36 |
ClinicalTrials.gov (NCT03298087) Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
|
| 37 |
ClinicalTrials.gov (NCT01547299) Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer
|
| 38 |
ClinicalTrials.gov (NCT05316935) GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
|
| 39 |
ClinicalTrials.gov (NCT03900637) PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate
|
| 40 |
ClinicalTrials.gov (NCT02770391) Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer
|
| 41 |
ClinicalTrials.gov (NCT02064582) Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
|
| 42 |
ClinicalTrials.gov (NCT00388804) External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
|
| 43 |
ClinicalTrials.gov (NCT02941926) Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC
|
| 44 |
ClinicalTrials.gov (NCT00002597) Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
|
| 45 |
ClinicalTrials.gov (NCT00541047) RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery
|
| 46 |
ClinicalTrials.gov (NCT02319837) Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
|
| 47 |
ClinicalTrials.gov (NCT04094467) Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection
|
|
|
|
|
|
|
